Oral salmon calcitonin pharmaceutical products

摘要

Bioavailability of salmon calcitonin to be administered orally is enhanced by a pharmaceutical composition providing targeted release of the peptide to the intestine, together with an absorption enhancer and a sufficient amount of a pH-lowering agent to lower local intestinal pH. Specific concentrations and classes of these agents are disclosed to account for the particular characteristics of salmon calcitonin.